Cargando…

Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome

The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protein required for translation of all eukaryotic genomes, is a surprising yet potent oncogenic driver. The genetic interactions that maintain the oncogenic activity of this key translation factor remain u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuzuoglu-Ozturk, Duygu, Hu, Zhiqiang, Rama, Martina, Devericks, Emily, Weiss, Jacob, Chiang, Gary G., Worland, Stephen T., Brenner, Steven E., Goodarzi, Hani, Gilbert, Luke A., Ruggero, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323864/
https://www.ncbi.nlm.nih.gov/pubmed/34192540
http://dx.doi.org/10.1016/j.celrep.2021.109321
Descripción
Sumario:The major cap-binding protein eukaryotic translation initiation factor 4E (eIF4E), an ancient protein required for translation of all eukaryotic genomes, is a surprising yet potent oncogenic driver. The genetic interactions that maintain the oncogenic activity of this key translation factor remain unknown. In this study, we carry out a genome-wide CRISPRi screen wherein we identify more than 600 genetic interactions that sustain eIF4E oncogenic activity. Our data show that eIF4E controls the translation of Tfeb, a key executer of the autophagy response. This autophagy survival response is triggered by mitochondrial proteotoxic stress, which allows cancer cell survival. Our screen also reveals a functional interaction between eIF4E and a single anti-apoptotic factor, Bcl-xL, in tumor growth. Furthermore, we show that eIF4E and the exon-junction complex (EJC), which is involved in many steps of RNA metabolism, interact to control the migratory properties of cancer cells. Overall, we uncover several cancer-specific vulnerabilities that provide further resolution of the cancer translatome.